{"transactions":[{"id":707880,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":30038,"kind":"organization","name":"Coastlands Capital LP","position":1,"cik":"0002068530","reported_name":"Coastlands Capital LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-07-16T21:08:32.000Z","date":"2026-07-16","kind":"purchase","planned":false,"acquired":true,"shares":1233,"price":2.75,"value":3390.75,"ownership":{"direct":false,"nature":"By Coastlands Capital LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Coastlands Capital LP (\"Coastlands\") and Coastlands Capital GP LLC (the \"General Partner\") are the investment adviser and general partner, respectively, of Coastlands Capital Partners LP, a Delaware limited partnership (the \"Partnership\"). Coastlands Capital LLC (\"Coastlands GP\") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that person's pecuniary interest therein."}],"balance_after":388308,"source":{"system":"sec-edgar","filing":"0001104659-26-084300","document":"tm2620655-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000110465926084300/tm2620655-1_4seq1.xml","form_type":"4"}},{"id":707879,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":30038,"kind":"organization","name":"Coastlands Capital LP","position":1,"cik":"0002068530","reported_name":"Coastlands Capital LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-07-16T21:08:32.000Z","date":"2026-07-14","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":2.65,"value":5300.0,"ownership":{"direct":false,"nature":"By Coastlands Capital LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Coastlands Capital LP (\"Coastlands\") and Coastlands Capital GP LLC (the \"General Partner\") are the investment adviser and general partner, respectively, of Coastlands Capital Partners LP, a Delaware limited partnership (the \"Partnership\"). Coastlands Capital LLC (\"Coastlands GP\") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that person's pecuniary interest therein."}],"balance_after":387075,"source":{"system":"sec-edgar","filing":"0001104659-26-084300","document":"tm2620655-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000110465926084300/tm2620655-1_4seq1.xml","form_type":"4"}},{"id":710502,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":30038,"kind":"organization","name":"Coastlands Capital LP","position":1,"cik":"0002068530","reported_name":"Coastlands Capital LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-07-13T14:30:34.000Z","date":"2026-07-10","kind":"purchase","planned":false,"acquired":true,"shares":1700,"price":2.7,"value":4590.0,"ownership":{"direct":false,"nature":"By Coastlands Capital LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Coastlands Capital LP (\"Coastlands\") and Coastlands Capital GP LLC (the \"General Partner\") are the investment adviser and general partner, respectively, of Coastlands Capital Partners LP, a Delaware limited partnership (the \"Partnership\"). Coastlands Capital LLC (\"Coastlands GP\") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that person's pecuniary interest therein."}],"balance_after":385075,"source":{"system":"sec-edgar","filing":"0001104659-26-082972","document":"tm2620210-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000110465926082972/tm2620210-1_4seq1.xml","form_type":"4"}},{"id":710501,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":30038,"kind":"organization","name":"Coastlands Capital LP","position":1,"cik":"0002068530","reported_name":"Coastlands Capital LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-07-13T14:30:34.000Z","date":"2026-07-09","kind":"purchase","planned":false,"acquired":true,"shares":10053,"price":2.79,"value":28047.87,"ownership":{"direct":false,"nature":"By Coastlands Capital LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Coastlands Capital LP (\"Coastlands\") and Coastlands Capital GP LLC (the \"General Partner\") are the investment adviser and general partner, respectively, of Coastlands Capital Partners LP, a Delaware limited partnership (the \"Partnership\"). Coastlands Capital LLC (\"Coastlands GP\") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that person's pecuniary interest therein."}],"balance_after":383375,"source":{"system":"sec-edgar","filing":"0001104659-26-082972","document":"tm2620210-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000110465926082972/tm2620210-1_4seq1.xml","form_type":"4"}},{"id":720770,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":30038,"kind":"organization","name":"Coastlands Capital LP","position":1,"cik":"0002068530","reported_name":"Coastlands Capital LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-07-01T14:30:13.000Z","date":"2026-06-29","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":2.6,"value":65000.0,"ownership":{"direct":false,"nature":"By Coastlands Capital LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Coastlands Capital LP (\"Coastlands\") and Coastlands Capital GP LLC (the \"General Partner\") are the investment adviser and general partner, respectively, of Coastlands Capital Partners LP, a Delaware limited partnership (the \"Partnership\"). Coastlands Capital LLC (\"Coastlands GP\") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that person's pecuniary interest therein."}],"balance_after":373322,"source":{"system":"sec-edgar","filing":"0001104659-26-079686","document":"tm2619520-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513525/000110465926079686/tm2619520-1_4seq1.xml","form_type":"4"}},{"id":729963,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":30038,"kind":"organization","name":"Coastlands Capital LP","position":1,"cik":"0002068530","reported_name":"Coastlands Capital LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-06-22T14:30:53.000Z","date":"2026-06-17","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":0.53,"value":53000.0,"ownership":{"direct":false,"nature":"By Coastlands Capital LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Coastlands Capital LP (\"Coastlands\") and Coastlands Capital GP LLC (the \"General Partner\") are the investment adviser and general partner, respectively, of Coastlands Capital Partners LP, a Delaware limited partnership (the \"Partnership\"). Coastlands Capital LLC (\"Coastlands GP\") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that person's pecuniary interest therein."}],"balance_after":3835035,"source":{"system":"sec-edgar","filing":"0001104659-26-076184","document":"tm2618440-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1841330/000110465926076184/tm2618440-1_4seq1.xml","form_type":"4"}},{"id":759120,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":30038,"kind":"organization","name":"Coastlands Capital LP","position":1,"cik":"0002068530","reported_name":"Coastlands Capital LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-funded Warrant","published_at":"2026-05-30T01:55:45.000Z","date":"2026-05-27","kind":"other","planned":false,"acquired":true,"shares":1250000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Coastlands Capital LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of that certain Amended and Restated Pre-Funded Warrant to Purchase Common Stock, dated as of April 27, 2026, Coastlands Capital Partners LP (the \"Partnership\"),\nexchanged 1,250,000 shares of common stock of the Issuer for pre-funded warrants to purchase an equivalent number of shares of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The pre-funded warrants to purchase shares of the Issuer's common stock (the \"Pre-Funded Warrants\") have no expiration date and are exercisable at any time after the date of issuance. A holder of\nPre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of common stock outstanding\nimmediately after giving effect to such exercise."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The pre-funded warrants to purchase shares of the Issuer's common stock (the \"Pre-Funded Warrants\") have no expiration date and are exercisable at any time after the date of issuance. A holder of\nPre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of common stock outstanding\nimmediately after giving effect to such exercise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Coastlands Capital LP (\"Coastlands\") and Coastlands Capital GP LLC (the \"General Partner\") are the investment adviser and general partner, respectively, of the Partnership. Coastlands Capital\nLLC (\"Coastlands GP\") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing\nthis Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that\nperson's pecuniary interest therein."}],"balance_after":30612243,"derivative":{"exercise_price":0.01,"underlying":"Common Stock","underlying_shares":1250000},"source":{"system":"sec-edgar","filing":"0001104659-26-068440","document":"tm2615865-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465926068440/tm2615865-2_4seq1.xml","form_type":"4"}},{"id":759119,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":30038,"kind":"organization","name":"Coastlands Capital LP","position":1,"cik":"0002068530","reported_name":"Coastlands Capital LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-30T01:55:45.000Z","date":"2026-05-27","kind":"other","planned":false,"acquired":false,"shares":1250000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Coastlands Capital LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of that certain Amended and Restated Pre-Funded Warrant to Purchase Common Stock, dated as of April 27, 2026, Coastlands Capital Partners LP (the \"Partnership\"),\nexchanged 1,250,000 shares of common stock of the Issuer for pre-funded warrants to purchase an equivalent number of shares of common stock of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Coastlands Capital LP (\"Coastlands\") and Coastlands Capital GP LLC (the \"General Partner\") are the investment adviser and general partner, respectively, of the Partnership. Coastlands Capital\nLLC (\"Coastlands GP\") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing\nthis Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that\nperson's pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-26-068440","document":"tm2615865-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465926068440/tm2615865-2_4seq1.xml","form_type":"4"}}]}